-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Downgrades Sionna Therapeutics to Neutral, Lowers Price Target to $5

Benzinga·08/11/2026 13:43:50
Listen to the news
Wedbush analyst Laura Chico downgrades Sionna Therapeutics (NASDAQ:SION) from Outperform to Neutral and lowers the price target from $53 to $5.